Skip to search formSkip to main contentSkip to account menu

Polysaccharide Vaccine

A category of vaccines that use the extracted and purified outer polysaccharide coat of the particular bacteria.
National Institutes of Health

Related topics

Related topics

5 relations
Polyvalent pneumococcal vaccineVaccinesVaccines, ConjugateVi Capsular Polysaccharide Typhoid Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.
RATIONALE Debate exists about the immunogenicity and protective efficacy of antibodies produced by the 23-valent pneumococcal… 
Highly Cited
2006
Highly Cited
2006
Multiplex PCR-Based Reverse Line Blot Hybridization Assay To Identify 23 Streptococcus pneumoniae Polysaccharide Vaccine Serotypes
ABSTRACT We developed a multiplex PCR-based reverse line blot assay to identify 23 pneumococcal serotypes represented in the… 
2005
2005
Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment.
Highly Cited
1999
Highly Cited
1999
A Flow Cytometric Opsonophagocytic Assay for Measurement of Functional Antibodies Elicited after Vaccination with the 23-Valent Pneumococcal Polysaccharide Vaccine
ABSTRACT Opsonophagocytosis is the primary mechanism for clearance of pneumococci from the host, and the measurement of… 
Highly Cited
1991
Highly Cited
1991
25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density.
Highly Cited
1988
Highly Cited
1988
Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal…
Ig class-, and IgA and IgG subclass-specific immune responses to a 23 valent pneumococcal polysaccharide vaccine were studied at… 
Highly Cited
1988
Highly Cited
1988
Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota.
We evaluated the efficacy of Haemophilus b polysaccharide vaccine in children in Minnesota using a case-control study. The… 
Highly Cited
1988
Highly Cited
1988
The protective efficacy of Haemophilus b polysaccharide vaccine.
To assess the protective efficacy of the Haemophilus b polysaccharide vaccine, a case-control study was conducted in Connecticut… 
Highly Cited
1986
Highly Cited
1986
Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.
We studied 55 cases of invasive Hemophilus influenzae type b disease occurring in children at least three weeks after vaccination… 
Highly Cited
1986
Highly Cited
1986
Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine.
In healthy persons IgG antibodies to polysaccharides are predominantly of the IgG2 subclass.1 2 3 Selective deficiency of this… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)